ALFA Finder
22:44 IST
BSE
Dividend
Gufic BioSciences Dividend
Gufic Biosciences recommended a final dividend of Re. 0.10 per equity share for financial year 2025-26. The distribution is subject to shareholder approval at the upcoming AGM.
Gufic BioSciences Ltd
- Share price
- ₹467.35
- Market cap
- ₹4,687 Cr
- Revenue (annual)
- ₹944.0 Cr
- Net profit (annual)
- ₹64.21 Cr
- P/E (TTM)
- 63.8×Sector 43.8×
- Promoter holding
- 72.50%+0.00% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 5Other Announcement 4Legal & Regulatory 4Financial Results 4Merger & Restructuring 3Board Meeting Date 3Management Change 2Business Update 2Board Meeting Outcome 2Annual General Meeting 2Acquisition 2Dividend 1Credit Rating 1Annual Report 1
Time
36 announcements with these filters
22:34 IST
BSE
Financial Results
Gufic BioSciences Financial Results
Gufic Biosciences reported consolidated total income of ₹946.66 Crore for FY26. The board also recommended a final dividend of ₹0.10 per equity share.
- Value
- ₹946.7 Cr
22:13 IST
BSE
Financial Results
Gufic BioSciences Q4 FY26 Results: Net Profit ₹21.9 Cr, Up 184.4% YoY
Gufic BioSciences Ltd reported revenue from operations of ₹251.8 Cr (+22.8% YoY) and net profit of ₹21.9 Cr (+184.4% YoY) for Q4 FY26.
- Key figure
- Net profit ₹21.9 Cr · +184.4% YoY
22:12 IST
BSE
Financial Results
Gufic BioSciences Financial Results
Gufic Biosciences reported audited FY26 results and recommended a 10% final dividend. The Board also approved a ₹5.75 Crore equity investment in Saraswat Co-operative Bank.
- Value
- ₹0.58 Cr
16:22 IST
BSE
Other Announcement
Gufic BioSciences Other Announcement
Gufic Biosciences submitted its Annual Secretarial Compliance Report for the financial year 2026. The report confirms overall regulatory compliance with noted historical fine payments.
17:28 IST
BSE
Board Meeting Date
Gufic BioSciences Board Meeting Date
Gufic Biosciences scheduled a May 29 board meeting to approve FY2026 audited results and consider a final dividend. Trading remains closed until 48 hours post-declaration.